El objetivo es entender qu dicen los datos, cmo responde el cuerpo y qu papel juega la conducta alimentaria en todo este proceso
This recognition serves as a reminder that our commitment to preventative health and obesity medicine is making a difference in our community
CMS is proposing temporary expansions of Medicare and Medicaid coverage of GLP-1s for obesity through demonstration programs CMS initially proposed a two-step approach to expanding coverage of GLP-1s for obesity in Medicare a temporary payment demonstration for 2026, known as the Medicare GLP-1 Bridge, and a new Center for Medicare and Medicaid Innovation (CMMI) model, known as the BALANCE Model, that was originally scheduled to begin in January 2027 and end in December 2031
Third-Party Tested for Quality: As part of our commitment to industry-leading transparency and quality, every batch of Transparent Labs Creatine HMB is third-party tested for purity and potency
Combination Therapy Changes the Equation If you are also taking glipizide, glimepiride, or insulin, your hypoglycemia risk is meaningfully higher
Can TB-500 and BPC-157 be used together